Biolargo Inc (BLGO)

$0.17 +0.00 (0.53%)
Market Cap 53.94M
Revenue (ttm) 7.77M
Net Income (ttm) -11.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -151.61%
Debt to Equity Ratio 0.33
Volume 48,600
Avg Vol 272,658
Day's Range N/A - N/A
Shares Out 318.23M
Stochastic %K 46%
Beta -0.03
Analysts Strong Buy
Price Target $0.36

Company Profile

BioLargo, Inc. invents, develops, and commercializes various platform technologies. The company's technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. It provides full-service environmental engineering services. BioLargo, Inc. is based in Westminst...

Industry: Chemicals
Sector: Basic Materials
Phone: 888 400 2863
Address:
14921 Chestnut Street, Westminster, United States
bkr365
bkr365 Mar. 18 at 10:00 AM
$BLGO Advanced Solution Setting a new gold standard in advanced wound care. ViaCLYR™ with ClyraSept™ is redefining wound irrigation by combining effective cleansing with advanced antimicrobial performance, supporting the removal of debris and microorganisms while maintaining an optimal wound environment. Designed for both acute and chronic wounds, this solution reflects a more advanced approach to care, where efficacy, safety, and clinical practicality come together to support better healing outcomes. To learn more, reach out to mailto:[email protected]. #WoundCare #AdvancedWoundCare #HealthcareInnovation #MedicalDevices #PatientCare #AdvancedSolution #WoundIrrigation https://www.linkedin.com/posts/woundcare-advancedwoundcare-healthcareinnovation-ugcPost-7439761028097179648-6vkw?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAAE_emmIBBGBWSxrmdGlnq6Fg_vumxdkY7AQ&utm_campaign=share_via
0 · Reply
bkr365
bkr365 Mar. 18 at 12:46 AM
$BLGO CLYRA Medical Technologies 🍀 On St. Patrick’s Day, many rely on luck. In wound care, we rely on technology that performs. Clyra’s copper‑iodine technology is designed to support clinicians with powerful, sustained antimicrobial control—helping make wound irrigation more effective and consistent. Here's what technology delivers: ✅ No need to rinse out. Safe for host tissue. ✅ Friendly with grafts and tissue substitutes. ✅ Preservative in solution with broad-spectrum and sustained antimicrobial activity. ✅ Demonstrated reductions of biofilms. ✅ No known bacterial or microbial resistance. 👉 How is your team approaching wound irrigation this year? Have you standardized your antimicrobial solution? 🍀💫Happy St Patrick's day #StPatricksDay #ClyraMedical #WoundCare #WoundIrrigation #CopperIodineTechnology #InfectionPrevention
0 · Reply
TradesBB
TradesBB Mar. 17 at 7:03 PM
$BLGO 48k volume. sigh
1 · Reply
julianjakobi
julianjakobi Mar. 17 at 5:45 PM
$BLGO in case you missed it. It’s a nice bullish outlook. This will go higher again- the value is growing and the price will follow. It always does. Adding daily ;) Step by step to lift off. 🚀📈 https://richardacavalli.wixsite.com/greenplanetmicrocaps/blgo-standout-for-huge-rally
0 · Reply
WL123
WL123 Mar. 17 at 4:55 PM
$BLGO If you see a reference to a Green Planet Microcap article, it is also paid for.
1 · Reply
LRMorris
LRMorris Mar. 17 at 2:42 PM
$BLGO JJ making up numbers again. The only thing Dennis Coward has succeeded in is moving money from your pockets to his. Maybe he should hire another board member or pay from some more fluff reporting.
1 · Reply
julianjakobi
julianjakobi Mar. 17 at 1:39 PM
$BLGO BioLargo (BLGO) technicals: after a long correction and consolidation, the chart shows a higher low and a tightening triangle, with selling pressure easing and volume stabilizing. First upside target ~0.25, then 0.40 and 0.60 if it breaks out with conviction; downside now looks relatively limited versus upside if commercialization catalysts hit. Do your own DD!
0 · Reply
WL123
WL123 Mar. 17 at 12:58 PM
$BLGO Surprise surprise! You may have seen some "Analyst Coverage" from John Newell. The key thing to understand about his BLGO coverage is buried in the fine print of his articles. John Newell of John Newell & Associates was retained and compensated as an independent contractor by Street Smart (an affiliate of Streetwise Reports) for writing his articles. Biolargo also pays Streetwise Reports a sponsorship fee separately. So his "Speculative Buy" on BioLargo is paid-for coverage. Looking across all of John Newell's coverage, he applies "Speculative Buy" ratings broadly across junior miners, uranium plays, copper explorers, AI mortgage companies, and now BLGO.
1 · Reply
BozoJoeClownShow
BozoJoeClownShow Mar. 17 at 11:27 AM
$BLGO Any posts about “whales” loading up are complete LIES. There is practically ZERO interest by “the tutes” and all the other nonsensical claims about this company with a track record of failure.
1 · Reply
BozoJoeClownShow
BozoJoeClownShow Mar. 16 at 6:14 PM
$BLGO Could be 2 for a quarter soon. LMAO
1 · Reply
Latest News on BLGO
No data available.
bkr365
bkr365 Mar. 18 at 10:00 AM
$BLGO Advanced Solution Setting a new gold standard in advanced wound care. ViaCLYR™ with ClyraSept™ is redefining wound irrigation by combining effective cleansing with advanced antimicrobial performance, supporting the removal of debris and microorganisms while maintaining an optimal wound environment. Designed for both acute and chronic wounds, this solution reflects a more advanced approach to care, where efficacy, safety, and clinical practicality come together to support better healing outcomes. To learn more, reach out to mailto:[email protected]. #WoundCare #AdvancedWoundCare #HealthcareInnovation #MedicalDevices #PatientCare #AdvancedSolution #WoundIrrigation https://www.linkedin.com/posts/woundcare-advancedwoundcare-healthcareinnovation-ugcPost-7439761028097179648-6vkw?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAAE_emmIBBGBWSxrmdGlnq6Fg_vumxdkY7AQ&utm_campaign=share_via
0 · Reply
bkr365
bkr365 Mar. 18 at 12:46 AM
$BLGO CLYRA Medical Technologies 🍀 On St. Patrick’s Day, many rely on luck. In wound care, we rely on technology that performs. Clyra’s copper‑iodine technology is designed to support clinicians with powerful, sustained antimicrobial control—helping make wound irrigation more effective and consistent. Here's what technology delivers: ✅ No need to rinse out. Safe for host tissue. ✅ Friendly with grafts and tissue substitutes. ✅ Preservative in solution with broad-spectrum and sustained antimicrobial activity. ✅ Demonstrated reductions of biofilms. ✅ No known bacterial or microbial resistance. 👉 How is your team approaching wound irrigation this year? Have you standardized your antimicrobial solution? 🍀💫Happy St Patrick's day #StPatricksDay #ClyraMedical #WoundCare #WoundIrrigation #CopperIodineTechnology #InfectionPrevention
0 · Reply
TradesBB
TradesBB Mar. 17 at 7:03 PM
$BLGO 48k volume. sigh
1 · Reply
julianjakobi
julianjakobi Mar. 17 at 5:45 PM
$BLGO in case you missed it. It’s a nice bullish outlook. This will go higher again- the value is growing and the price will follow. It always does. Adding daily ;) Step by step to lift off. 🚀📈 https://richardacavalli.wixsite.com/greenplanetmicrocaps/blgo-standout-for-huge-rally
0 · Reply
WL123
WL123 Mar. 17 at 4:55 PM
$BLGO If you see a reference to a Green Planet Microcap article, it is also paid for.
1 · Reply
LRMorris
LRMorris Mar. 17 at 2:42 PM
$BLGO JJ making up numbers again. The only thing Dennis Coward has succeeded in is moving money from your pockets to his. Maybe he should hire another board member or pay from some more fluff reporting.
1 · Reply
julianjakobi
julianjakobi Mar. 17 at 1:39 PM
$BLGO BioLargo (BLGO) technicals: after a long correction and consolidation, the chart shows a higher low and a tightening triangle, with selling pressure easing and volume stabilizing. First upside target ~0.25, then 0.40 and 0.60 if it breaks out with conviction; downside now looks relatively limited versus upside if commercialization catalysts hit. Do your own DD!
0 · Reply
WL123
WL123 Mar. 17 at 12:58 PM
$BLGO Surprise surprise! You may have seen some "Analyst Coverage" from John Newell. The key thing to understand about his BLGO coverage is buried in the fine print of his articles. John Newell of John Newell & Associates was retained and compensated as an independent contractor by Street Smart (an affiliate of Streetwise Reports) for writing his articles. Biolargo also pays Streetwise Reports a sponsorship fee separately. So his "Speculative Buy" on BioLargo is paid-for coverage. Looking across all of John Newell's coverage, he applies "Speculative Buy" ratings broadly across junior miners, uranium plays, copper explorers, AI mortgage companies, and now BLGO.
1 · Reply
BozoJoeClownShow
BozoJoeClownShow Mar. 17 at 11:27 AM
$BLGO Any posts about “whales” loading up are complete LIES. There is practically ZERO interest by “the tutes” and all the other nonsensical claims about this company with a track record of failure.
1 · Reply
BozoJoeClownShow
BozoJoeClownShow Mar. 16 at 6:14 PM
$BLGO Could be 2 for a quarter soon. LMAO
1 · Reply
WL123
WL123 Mar. 16 at 4:53 PM
$BLGO A warning for the new eyes: JJ presents himself as an objective BioLargo community resource while operating with an undisclosed financial entanglement: Clyra Medical, a BioLargo subsidiary, sponsored his wife's film festival, a direct flow of company funds into his household. This matters because JJ moderates investor forums (Reddit, Discord) where he bans bearish participants and deletes post or comments he does not like. On forums like this he flood-posts repetitive content to push any post he does not like down the feed. The pattern is textbook: control the narrative, bury the dissent, never disclose the conflict. The irony is that this behavior actually hurts BioLargo long-term. Companies with healthy investor communities can stress-test their thesis, absorb criticism constructively, and attract serious institutional interest. What JJ has built is a sentiment bubble. The question worth asking: does BioLargo's management know this is happening, and if so, do they sanction it?
2 · Reply
julianjakobi
julianjakobi Mar. 16 at 4:28 PM
$BLGO for all the new eyes on BLGO. Here is a great recent summary article - that sees it as a „speculative buy“. Looking forward when this will hit the next targets $. 25, .40 and .60 .. Multiple X is coming. https://www.streetwisereports.com/article/2026/03/11/a-new-infection-control-platform-launched.html 📈
0 · Reply
WL123
WL123 Mar. 16 at 4:09 PM
$BLGO BioLargo has been "on the verge" of commercial breakthrough for roughly two decades. The company has mastered one product above all others: the press release. "Forbes Council Member" lets executives pay for the right to publish articles on Forbes and display a badges, creating the appearance of editorial endorsement when it's actually a paid membership product. Another part of the propaganda machine is JJ. He presents himself as an objective BioLargo community resource but any time there is a bearish post he spams repeat post to bury it down the feed. More to come one him...
0 · Reply
julianjakobi
julianjakobi Mar. 16 at 2:11 PM
$BLGO from the CEO‘s linkedin -Step by step.. can’t wait for BioLargo to get discovered. Very bullish. https://www.linkedin.com/posts/dennispcalvert_how-american-companies-can-power-the-world-activity-7439308343321710592-nG9_?utm_medium=ios_app&rcm=ACoAAAKJPNABCS5L0NbILT39LXumL_SwDh5n5do&utm_source=social_share_send&utm_campaign=copy_link
0 · Reply
WL123
WL123 Mar. 16 at 1:42 PM
$BLGO Forbes Counsil Member means nothing. It lets executives pay for the right to publish articles and display "Forbes Council Member" badges, creating the appearance of editorial endorsement when it's actually a paid membership product. This article is a credential-laundering advertorial dressed up as policy thought leadership. Dennis spends the whole article name-dropping his advisory committee role (1 of 42 people), citing MIT/WEF/The Economist to sound rigorous, and dispensing vague CEO-speak all to establish authority for what is essentially a BioLargo-style commercial pitch for environmental/water/PFAS technologies that conveniently align with their business interests. If Cellinity was the next big thing they or someone else would put some money forward to build a factory instead of begging for tax payer money to fund what will (if it ever happens) be a long arduous design and development cycle. https://www.forbes.com/councils/forbesbusinesscouncil/2026/03/16/how-american-companies-can-power-the-worlds-ai-future/
1 · Reply
julianjakobi
julianjakobi Mar. 16 at 1:23 PM
$BLGO Article by the BioLargo CEO Dennis Calvert- Forbes Council Member. https://www.forbes.com/councils/forbesbusinesscouncil/2026/03/16/how-american-companies-can-power-the-worlds-ai-future/
0 · Reply
julianjakobi
julianjakobi Mar. 16 at 12:55 PM
$BLGO Step By Step. Very Bullish! https://www.forbes.com/councils/forbesbusinesscouncil/2026/03/16/how-american-companies-can-power-the-worlds-ai-future/
1 · Reply
julianjakobi
julianjakobi Mar. 14 at 4:43 PM
$BLGO great news! https://www.linkedin.com/posts/dennispcalvert_cellinity-ettac-share-7438598670939484160-FZQo?utm_source=share&utm_medium=member_ios&rcm=ACoAAAdd6oMBHkrJzINwZ-5z-8ZtNA8QidL3Aqs
0 · Reply
julianjakobi
julianjakobi Mar. 14 at 3:34 PM
$BLGO great new Deck. Do your own DD. https://www.sec.gov/Archives/edgar/data/880242/000143774926007044/ex_929177.htm
0 · Reply
BozoJoeClownShow
BozoJoeClownShow Mar. 13 at 6:54 PM
$BLGO LMAO. Only thing more retarded is anyone who still pays any attention to this asshat.
2 · Reply
BozoJoeClownShow
BozoJoeClownShow Mar. 13 at 6:35 PM
$BLGO Loser has been lying since at least 2018.
1 · Reply
loucap81
loucap81 Mar. 12 at 8:17 PM
$BLGO https://www.linkedin.com/posts/clyramedical_were-excited-to-introduce-viaclyr-with-activity-7437947473899356160-11FN?utm_medium=ios_app&rcm=ACoAAC_IAFQB4iMjibaiYqghN3X9B7uDxBnw8tk&utm_source=social_share_send&utm_campaign=copy_link
0 · Reply